Genocea Biosciences Inc. | Key People and Executives
William D. Clark
President, Chief Executive Officer & Director
George R. Siber
Executive Director
Katrine S. Bosley
Chairman
Ali Behbahani
Independent Director
Howard Mayer
Independent Director
Ronald Cooper
Independent Director
Michael J. Higgins
Independent Director
Kenneth M. Bate
Independent Director
William D. Clark
President, Chief Executive Officer & Director
Michael Alfieri
VP-Finance, Chief Financial & Accounting Officer
Jessica Baker Flechtner
Chief Scientific Officer
Narinder Singh
Senior VP-Pharmaceutical Sciences & Manufacturing
Eric S. Hoffman
Chief Business Officer
George R. Siber
Executive Director
Jennifer LaVin
Press Contact
Katrine S. Bosley
Chairman
Ali Behbahani
Independent Director
Howard Mayer
Independent Director
Ronald H. W. Cooper
Independent Director
Michael John Higgins
Independent Director
Kenneth M. Bate
Independent Director
| Address |
Cambridge Discovery Park
Cambridge Massachusetts 02140
United States
|
|
Employees
|
- |
| Website |
http://www.genocea.com |
| Updated |
07/08/2019 |
| Genocea Biosciences engages in the development and commercialization of cancer vaccines. It uses its proprietary technology platform ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-003, an investigational immunotherapy for the treatment of genital herpes; and GEN-009, a neoantigen cancer vaccine. |
